{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:22:23Z","timestamp":1790400143385,"version":"4.1.0"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2006,6,20]],"date-time":"2006-06-20T00:00:00Z","timestamp":1150761600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.0030217","type":"journal-article","created":{"date-parts":[[2006,6,12]],"date-time":"2006-06-12T16:55:50Z","timestamp":1150131350000},"page":"e217","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":57,"title":["The BARD1 Cys557Ser Variant and Breast Cancer Risk in Iceland"],"prefix":"10.1371","volume":"3","author":[{"given":"Simon N","family":"Stacey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Sulem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar T","family":"Johannsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnar","family":"Helgason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Gudmundsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena P","family":"Kostic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristleifur","family":"Kristjansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thora","family":"Jonsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helgi","family":"Sigurdsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Hrafnkelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Johannsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorarinn","family":"Sveinsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gardar","family":"Myrdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hlynur Niels","family":"Grimsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon T","family":"Bergthorsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laufey T","family":"Amundadottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R","family":"Gulcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unnur","family":"Thorsteinsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustine","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Stefansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2006,6,20]]},"reference":[{"key":"pmed-0030217-b001","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/bcr6","article-title":"How many more breast cancer predisposition genes are there?","volume":"1","year":"1999","journal-title":"Breast Cancer Res"},{"key":"pmed-0030217-b002","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/ng1107","article-title":"The genetics and genomics of cancer.","volume":"33","year":"2003","journal-title":"Nat Genet"},{"key":"pmed-0030217-b003","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJM200007133430201","article-title":"Environmental and heritable factors in the causation of cancer\u2014Analyses of cohorts of twins from Sweden, Denmark, and Finland.","volume":"343","year":"2000","journal-title":"N Engl J Med"},{"key":"pmed-0030217-b004","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/82533","article-title":"High constant incidence in twins and other relatives of women with breast cancer.","volume":"26","year":"2000","journal-title":"Nat Genet"},{"key":"pmed-0030217-b005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/gepi.1014","article-title":"Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study.","volume":"21","year":"2001","journal-title":"Genet Epidemiol"},{"key":"pmed-0030217-b006","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/sj.bjc.6600008","article-title":"A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes.","volume":"86","year":"2002","journal-title":"Br J Cancer"},{"key":"pmed-0030217-b007","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ng853","article-title":"Polygenic susceptibility to breast cancer and implications for prevention.","volume":"31","year":"2002","journal-title":"Nat Genet"},{"key":"pmed-0030217-b008","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1371\/journal.pmed.0010065","article-title":"Cancer as a complex Phenotype: Pattern of cancer distribution within and beyond the nuclear family.","volume":"1","year":"2004","journal-title":"PLoS Med"},{"key":"pmed-0030217-b009","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/jmg.39.7.457","article-title":"The effect of a single BRCA2 mutation on cancer in Iceland.","volume":"39","year":"2002","journal-title":"J Med Genet"},{"key":"pmed-0030217-b010","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/jmg.35.6.446","article-title":"A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: Two recurrent mutations seem to account for all BRCA1\/BRCA2 linked breast cancer in Iceland.","volume":"35","year":"1998","journal-title":"J Med Genet"},{"key":"pmed-0030217-b011","first-page":"S195","article-title":"Identification of a novel splice-site mutation of the BRCA1 gene in two breast cancer families: Screening reveals low frequency in Icelandic breast cancer patients.","volume":"1","year":"1998","journal-title":"Hum Mutat Suppl"},{"key":"pmed-0030217-b012","first-page":"1079","article-title":"Study of a single BRCA2 mutation with high carrier frequency in a small population.","volume":"60","year":"1997","journal-title":"Am J Hum Genet"},{"key":"pmed-0030217-b013","first-page":"749","article-title":"Frequent occurrence of BRCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA2 haplotype.","volume":"58","year":"1996","journal-title":"Am J Hum Genet"},{"key":"pmed-0030217-b014","doi-asserted-by":"crossref","first-page":"7926","DOI":"10.1128\/MCB.23.21.7926-7936.2003","article-title":"BARD1 participates with BRCA1 in homology-directed repair of chromosome breaks.","volume":"23","year":"2003","journal-title":"Mol Cell Biol"},{"key":"pmed-0030217-b015","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0959-437X(01)00269-6","article-title":"The BRCA1\/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity.","volume":"12","year":"2002","journal-title":"Curr Opin Genet Dev"},{"key":"pmed-0030217-b016","doi-asserted-by":"crossref","first-page":"12078","DOI":"10.1073\/pnas.211427098","article-title":"Functional communication between endogenous BRCA1 and its partner, BARD1, during \n\t\t\t\t\t\tXenopus laevis development.","volume":"98","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pmed-0030217-b017","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1128\/MCB.23.14.5056-5063.2003","article-title":"Loss of Bard1, the heterodimeric partner of the Brca1 tumor suppressor, results in early embryonic lethality and chromosomal instability.","volume":"23","year":"2003","journal-title":"Mol Cell Biol"},{"key":"pmed-0030217-b018","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S1357-2725(01)00161-3","article-title":"BRCA1-dependent and independent functions of BARD1.","volume":"34","year":"2002","journal-title":"Int J Biochem Cell Biol"},{"key":"pmed-0030217-b019","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S1097-2765(01)00406-3","article-title":"Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis.","volume":"8","year":"2001","journal-title":"Mol Cell"},{"key":"pmed-0030217-b020","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1038\/sj.onc.1207302","article-title":"Nuclear-cytoplasmic shuttling of BARD1 contributes to its proapoptotic activity and is regulated by dimerization with BRCA1.","volume":"23","year":"2004","journal-title":"Oncogene"},{"key":"pmed-0030217-b021","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.yexcr.2004.05.004","article-title":"BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention.","volume":"298","year":"2004","journal-title":"Exp Cell Res"},{"key":"pmed-0030217-b022","doi-asserted-by":"crossref","first-page":"14537","DOI":"10.1074\/jbc.C000881200","article-title":"The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.","volume":"276","year":"2001","journal-title":"J Biol Chem"},{"key":"pmed-0030217-b023","doi-asserted-by":"crossref","first-page":"41399","DOI":"10.1074\/jbc.M106551200","article-title":"BRCA1 RING domain cancer-predisposing mutations. Structural consequences and effects on protein-protein interactions.","volume":"276","year":"2001","journal-title":"J Biol Chem"},{"key":"pmed-0030217-b024","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/gcc.1223","article-title":"Germline mutations of the BRCA1-associated ring domain (BARD1) gene in breast and breast\/ovarian families negative for BRCA1 and BRCA2 alterations.","volume":"33","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"pmed-0030217-b025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3835(03)00387-2","article-title":"Mutational analysis of BARD1 in familial breast cancer patients in Japan.","volume":"200","year":"2003","journal-title":"Cancer Lett"},{"key":"pmed-0030217-b026","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1136\/jmg.2004.020669","article-title":"Mutation screening of the BARD1 gene: Evidence for involvement of the Cys557Ser allele in hereditary susceptibility to breast cancer.","volume":"41","year":"2004","journal-title":"J Med Genet"},{"key":"pmed-0030217-b027","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/hmg\/7.2.195","article-title":"Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers.","volume":"7","year":"1998","journal-title":"Hum Mol Genet"},{"key":"pmed-0030217-b028","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1038\/sj.onc.1207427","article-title":"Nuclear-cytoplasmic translocation of BARD1 is linked to its apoptotic activity.","volume":"23","year":"2004","journal-title":"Oncogene"},{"key":"pmed-0030217-b029","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0092-8674(01)00270-7","article-title":"The BARD1\u2013CstF-50 interaction links mRNA 3\u2032 end formation to DNA damage and tumor suppression.","volume":"104","year":"2001","journal-title":"Cell"},{"key":"pmed-0030217-b030","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1038\/sj.onc.1202717","article-title":"The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB\/Rel and nuclear co-regulators.","volume":"18","year":"1999","journal-title":"Oncogene"},{"key":"pmed-0030217-b031","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/jmg.2004.030049","article-title":"Identification and characterization of missense alterations in the BRCA1 associated RING domain (BARD1) gene in breast and ovarian cancer.","volume":"42","year":"2005","journal-title":"J Med Genet"},{"key":"pmed-0030217-b032","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/sj.ejhg.5200530","article-title":"Protection of privacy by third-party encryption in genetic research in Iceland.","volume":"8","year":"2000","journal-title":"Eur J Hum Genet"},{"key":"pmed-0030217-b033","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/75514","article-title":"Allegro, a new computer program for multipoint linkage analysis.","volume":"25","year":"2000","journal-title":"Nat Genet"},{"key":"pmed-0030217-b034","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ng1245","article-title":"The gene encoding phosphodiesterase 4D confers risk of ischemic stroke.","volume":"35","year":"2003","journal-title":"Nat Genet"},{"key":"pmed-0030217-b035","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1086\/302902","article-title":"The mutation rate in the human mtDNA control region.","volume":"66","year":"2000","journal-title":"Am J Hum Genet"},{"key":"pmed-0030217-b036","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1086\/421251","article-title":"CHEK2*1100delC and susceptibility to breast cancer: A collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies.","volume":"74","author":"CHEK2 Breast Cancer Case-Control Consortium","year":"2004","journal-title":"Am J Hum Genet"},{"key":"pmed-0030217-b037","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng879","article-title":"Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations.","volume":"31","year":"2002","journal-title":"Nat Genet"},{"key":"pmed-0030217-b038","first-page":"2378","article-title":"Familiality of cancer in Utah.","volume":"54","year":"1994","journal-title":"Cancer Res"},{"key":"pmed-0030217-b039","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/ng1492","article-title":"An Icelandic example of the impact of population structure on association studies.","volume":"37","year":"2005","journal-title":"Nat Genet"},{"key":"pmed-0030217-b040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/978-3-642-55647-0_2","article-title":"Genetic susceptibility, predicting risk and preventing cancer.","volume":"163","year":"2003","journal-title":"Recent Results Cancer Res"},{"key":"pmed-0030217-b041","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/35077207","article-title":"Cancer genetics.","volume":"411","year":"2001","journal-title":"Nature"},{"key":"pmed-0030217-b042","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.1038\/sj.onc.1207951","article-title":"The search for low-penetrance cancer susceptibility alleles.","volume":"23","year":"2004","journal-title":"Oncogene"},{"key":"pmed-0030217-b043","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1086\/341943","article-title":"A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer.","volume":"71","year":"2002","journal-title":"Am J Hum Genet"},{"key":"pmed-0030217-b044","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/1097-0142(19820701)50:1<171::AID-CNCR2820500132>3.0.CO;2-M","article-title":"Epidemiology of breast carcinoma III: Relationship of family history to tumor type.","volume":"50","year":"1982","journal-title":"Cancer"},{"key":"pmed-0030217-b045","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00007611-198001000-00012","article-title":"Morphologic types of breast cancer: Age, bilaterality, and family history.","volume":"73","year":"1980","journal-title":"South Med J"},{"key":"pmed-0030217-b046","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ijc.21236","article-title":"Lobular breast cancer: Excess familiality observed in the Utah Population Database.","volume":"117","year":"2005","journal-title":"Int J Cancer"},{"key":"pmed-0030217-b047","first-page":"782","article-title":"The pathology of familial breast cancer: Histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2.","volume":"6","year":"2000","journal-title":"Clin Cancer Res"},{"key":"pmed-0030217-b048","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/bcr10","article-title":"The pathology of familial breast cancer: Morphological aspects.","volume":"1","year":"1999","journal-title":"Breast Cancer Res"},{"key":"pmed-0030217-b049","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(96)10109-4","article-title":"Pathology of familial breast cancer: Differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases.","volume":"349","author":"Breast Cancer Linkage Consortium","year":"1997","journal-title":"Lancet"},{"key":"pmed-0030217-b050","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/(SICI)1097-0142(19960215)77:4<697::AID-CNCR16>3.0.CO;2-W","article-title":"Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage.","volume":"77","year":"1996","journal-title":"Cancer"},{"key":"pmed-0030217-b051","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/B:BREA.0000021049.61839.e5","article-title":"Are medullary breast cancers an indication for BRCA1 mutation screening? A mutation analysis of 42 cases of medullary breast cancer.","volume":"85","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"pmed-0030217-b052","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1200\/JCO.1998.16.2.397","article-title":"Survival of BRCA1 breast and ovarian cancer patients: A population-based study from southern Sweden.","volume":"16","year":"1998","journal-title":"J Clin Oncol"},{"key":"pmed-0030217-b053","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1200\/JCO.1998.16.5.1642","article-title":"BRCA-associated breast cancer in young women.","volume":"16","year":"1998","journal-title":"J Clin Oncol"},{"key":"pmed-0030217-b054","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(97)07065-7","article-title":"Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.","volume":"351","year":"1998","journal-title":"Lancet"},{"key":"pmed-0030217-b055","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","article-title":"Cancer statistics, 2005.","volume":"55","year":"2005","journal-title":"CA Cancer J Clin"}],"container-title":["PLoS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.0030217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T18:24:21Z","timestamp":1588875861000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.0030217"}},"subtitle":[],"editor":[{"given":"Cathryn","family":"Lewis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2006,6,20]]},"references-count":55,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2006,6,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.0030217","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6,20]]}}}